Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94397007 | 9439700 | 7 | F | 20130728 | 20160830 | 20130805 | 20160912 | EXP | US-PFIZER INC-2013224396 | PFIZER | 60.00 | YR | F | Y | 98.41000 | KG | 20160912 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94397007 | 9439700 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 37.5 MG, DAILY | U | 21938 | 37.5 | MG | CAPSULE, HARD | ||||||
| 94397007 | 9439700 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 12.5 MG, UNK | U | 21938 | 12.5 | MG | CAPSULE, HARD | ||||||
| 94397007 | 9439700 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 25 MG, CYCLIC (DAILY, FOR 2 WEEKS ON AND 1 WEEK OFF) | U | 21938 | 25 | MG | CAPSULE, HARD | ||||||
| 94397007 | 9439700 | 4 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 37.5 MG, 3 WEEKS ON AND 1 WK OFF | U | 21938 | 37.5 | MG | CAPSULE, HARD | ||||||
| 94397007 | 9439700 | 5 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 37.5 MG, 2WKS ON AND 1 WK OFF | U | 21938 | 37.5 | MG | CAPSULE, HARD | ||||||
| 94397007 | 9439700 | 6 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 20 MG, 21 DAYS ON 7 DAYS OFF | U | 21938 | 20 | MG | CAPSULE, HARD | ||||||
| 94397007 | 9439700 | 7 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 12.5 MG, 2X/DAY (14 DAYS AND THEN 7 DAYS OFF) | U | 21938 | 12.5 | MG | CAPSULE, HARD | BID | |||||
| 94397007 | 9439700 | 8 | SS | SUTENT | SUNITINIB MALATE | 1 | UNK | U | 21938 | CAPSULE, HARD | |||||||||
| 94397007 | 9439700 | 9 | C | ALOE BARBADENSIS | 2 | UNK | 0 | ||||||||||||
| 94397007 | 9439700 | 10 | C | ASPIRIN. | ASPIRIN | 1 | UNK | 0 | |||||||||||
| 94397007 | 9439700 | 11 | C | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | 20 MG DAILY | 0 | 20 | MG | |||||||||
| 94397007 | 9439700 | 12 | C | CLOBETA | CLOBETASOL PROPIONATECOAL TAR | 1 | UNK | 0 | OINTMENT | ||||||||||
| 94397007 | 9439700 | 13 | C | DICYCLOMINE HYDROCHLORIDE. | DICYCLOMINE HYDROCHLORIDE | 1 | 20 MG TWICE DAILY | 0 | 20 | MG | BID | ||||||||
| 94397007 | 9439700 | 14 | C | DIOVAN HCT | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | 160/25 DAILY | 0 | |||||||||||
| 94397007 | 9439700 | 15 | C | METOCLOPRAMIDE HYDROCHLORIDE. | METOCLOPRAMIDE HYDROCHLORIDE | 1 | 5 TO 10 MG BEFORE MEALS AND AT BEDTIME | 0 | |||||||||||
| 94397007 | 9439700 | 16 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | UNK | 0 | |||||||||||
| 94397007 | 9439700 | 17 | C | SERTRALINE HYDROCHLORIDE. | SERTRALINE HYDROCHLORIDE | 1 | 150 EVERY MORNING | 0 | QD | ||||||||||
| 94397007 | 9439700 | 18 | C | TRAZODONE HYDROCHLORIDE. | TRAZODONE HYDROCHLORIDE | 1 | 75 MG IN THE EVENING | 0 | 75 | MG | QD | ||||||||
| 94397007 | 9439700 | 19 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 94397007 | 9439700 | 20 | C | ASA | ASPIRIN | 1 | 81 MG, DAILY | 0 | 81 | MG | |||||||||
| 94397007 | 9439700 | 21 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | 40 MG, DAILY | 0 | 40 | MG | |||||||||
| 94397007 | 9439700 | 22 | C | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | 24000 U, (4 CAPSULES WITH EACH MEAL) | 0 | 4 | DF | CAPSULE | ||||||||
| 94397007 | 9439700 | 23 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 150 MG IN THE P.M. | 0 | 150 | MG | QD | ||||||||
| 94397007 | 9439700 | 24 | C | NOVOLOG | INSULIN ASPART | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 94397007 | 9439700 | 1 | Pancreatic neuroendocrine tumour metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 94397007 | 9439700 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 94397007 | 9439700 | Abdominal pain | |
| 94397007 | 9439700 | Back pain | |
| 94397007 | 9439700 | Blood pressure increased | |
| 94397007 | 9439700 | Diarrhoea | |
| 94397007 | 9439700 | Disease progression | |
| 94397007 | 9439700 | Dysgeusia | |
| 94397007 | 9439700 | Epistaxis | |
| 94397007 | 9439700 | Erythema | |
| 94397007 | 9439700 | Fatigue | |
| 94397007 | 9439700 | Flatulence | |
| 94397007 | 9439700 | Gingival pain | |
| 94397007 | 9439700 | Headache | |
| 94397007 | 9439700 | Nephrolithiasis | |
| 94397007 | 9439700 | Overweight | |
| 94397007 | 9439700 | Palmar-plantar erythrodysaesthesia syndrome | |
| 94397007 | 9439700 | Pancreatic neuroendocrine tumour metastatic | |
| 94397007 | 9439700 | Pelvic pain | |
| 94397007 | 9439700 | Pruritus | |
| 94397007 | 9439700 | Raynaud's phenomenon |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 94397007 | 9439700 | 1 | 20130704 | 0 | ||
| 94397007 | 9439700 | 2 | 20130710 | 0 | ||
| 94397007 | 9439700 | 3 | 2013 | 0 | ||
| 94397007 | 9439700 | 4 | 20130907 | 0 | ||
| 94397007 | 9439700 | 5 | 20131121 | 0 | ||
| 94397007 | 9439700 | 6 | 20141007 | 0 |